29-09-2025
Morgan Stanley analysts say a trial to test whether Novo Nordisk’s blockbuster weight-loss drug also will work against Alzheimer’s is likely to fail, as it set the most pessimistic target price forecast of any Wall Street bank on the Danish drugmaker.
29-09-2025
Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.
29-09-2025
“My husband jokes that he will never be able to retire because we do not own a home.”
29-09-2025
Gavekal Research predicts more stock repurchases are coming, representing an additional tailwind for the current bull market.